3,511 results found

In an action commenced by Allergan against Apotex in respect of ulipristal (Allergan's FIBRISTAL) under the Patent Medicines (Notice of Compliance) Regulations (PMNOC ...

As previously reported, on December 2, 2017, Canada's Governor-in-Council published proposed Regulations Amending the Patented Medicines Regulations for comment.

The Supreme Court of Canada has issued a landmark ruling on whether methods of medical treatment can be patented in Canada, addressing a long-standing prohibition that has shaped the country's intellectual property landscape. The decision examines the boundaries between patentable medical innovations and unpatentable professional medical judgment, with particular focus on dosing regimens and treatment protocols. This ruling provides critical guidance for pharmaceutical companies, patent practitioners, and h

Eli Lilly seeks leave in olanzapine section 8 damages action.

As previously reported, the Federal Court of Appeal (FCA) dismissed Teva's appeal on the quantification of damages from infringement of Janssen's patent for levofloxacin (LEVAQUIN).

The legalization of recreational cannabis this October raises significant safety concerns for contractors. Legalization will bring easier access to cannabis and end the social stigma of using an illegal drug.

Some residential landlords want to be able to ban the use of marijuana smoking in rental units when recreational use is legalized.

Our fifth annual Legal Year in Review contains our observations about some of the most significant legal developments affecting Canadian business over the past year and their implications for 2019 and beyond.

Mondaq Article Editorial -Wednesday, October 9, 2024

​Vous pouvez maintenant télécharger notre rapport annuel de leadership éclairé.

Our annual thought leadership report is now available to download.

On October 13, 2021, Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced that it had closed its previously announced private placement of common shares and warrants...

On June 12, 2019, Gabriella's Kitchen Inc. ("GABY") (CSE: GABY) (OTCQB: GABLF) announced that it had closed its previously announced upsized brokered private placement offering led by GMP Securities

Members of Torys' Food and Drug Regulatory team, Eileen McMahon, Teresa Reguly, Yolande Dufresne and Manpreet Singh...

The Report includes information regarding trends in listing on the Patent Register and the Register of Innovative Drugs, as well as related court activity.

In January 2018, Advertising Standards Canada ("Ad Standards") published an updated Guidelines for Consumer Advertising of Health Products.

As of June 30, Health Canada had approved 16 biosimilars, based on 11 comparator products (3 in 2019).

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.